CompletedNCT00753506
Artemisinin or placebo for schizophrenia symptoms
About this title
Read the official source — NCT00753506Placebo comparisonAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- TowsonSee all locations and recruitment
Study information
Study start dateAugust 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 66
- Sponsor
- Sheppard Pratt Health System
- Sponsor type
- Unknown or unclear
- Study type
- Other
- Intervention type
- DIETARY_SUPPLEMENT
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00753506
- Official title
Show the full official title
Double-Blind Trial of Artemisinin to Reduce The Symptoms of Schizophrenia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Towson
Questions about this study
Who is behind this study?
The study sponsor is Sheppard Pratt Health System.
Who was this study for?
Listed age limits: 18 years to 65 years.
